We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes
Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing
As McDonald’s is targeted, governments also need to tighten and enforce rules
Neurotechnology restores natural gait with device that decodes brain’s signals for people with spinal injuries
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
The organ recovery technique has provoked criticism from within the scientific community
Human life appears to have an upper limit that has yet to be extended
Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work
Our craving for human company causes psychological stress, which induces physiological effects
Mental health has deteriorated since 2019 with young impacted most, data shows
Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago
US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic
Shadow health secretary sets out plan to boost clinical research
From India to Britain, we have always managed to get in the way of our own inventiveness
Viral disease previously known as monkeypox has caused more than 87,000 infections and 140 deaths
One in 5 biomedical articles may contain faked data, with Chinese paper mills leading way
Project discovers more variation in DNA than expected, offering insights into human diversity
A demonised elite produced vaccines and furloughs while a supposedly rebellious public mostly followed the rules
In clinical trials, the medications slowed the progress of the degenerative disease that affects 50mn worldwide
UN health body declares end to acute phase of pandemic after at least 20mn deaths
Biggest biomedical charity makes first investment in science infrastructure from its endowment
Also in this newsletter: Should an American economist lead EU competition policy?
Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases
European health officials have advocated portfolio diversity to help fight different variants
The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?
International Edition
